Connection

Jean-Charles Soria to Enzyme Inhibitors

Back to Details
This is a "connection" page, showing publications Jean-Charles Soria has written about Enzyme Inhibitors.
Jean-Charles Soria
Connection Strength
0.083
Enzyme Inhibitors
  1. Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study. Lancet Oncol. 2018 05; 19(5):649-659.
    View in: PubMed
    Score: 0.083
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.